Navigation Links
Cell Therapeutics, Inc. (CTI) to Present at Three Upcoming Investor Conferences
Date:10/12/2008

SEATTLE, Oct. 13 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) has been selected to present at three upcoming investor conferences. The conferences include the 7th Annual BIO Investor Forum in San Francisco in October, the 19th Annual Oppenheimer & Co. Healthcare Conference, and the 9th Annual Acumen BioFin Rodman & Renshaw Healthcare Conference in November, both in New York City.

The presentations will be webcast live with slides, and available for replay after the presentation at http://www.celltherapeutics.com.

BIO Investor Forum

CTI Presentation: Thursday, October 30, 2008

8:00 AM PT/11:00 AM ET/4:00 PM CET

Room TBA, Palace Hotel, San Francisco

Oppenheimer & Co. Healthcare Conference

CTI Presentation: Monday, November 3, 2008

8:00 AM ET/2:00 PM CET/5:00 AM PT

Astor Room, Waldorf-Astoria Hotel, New York City

Acumen BioFin Rodman & Renshaw Healthcare Conference

CTI Presentation: Tuesday, November 11, 2008

10:45 AM EST/4:45 PM CET/7:45 AM PST

Kennedy I, New York Palace Hotel, New York City

Media Contact: Investors Contact:

Cell Therapeutics, Inc. Cell Therapeutics, Inc.

Dan Eramian Ed Bell

T: 206.272.4343 T: 206.272.4345

F: 206.272.4434 Lindsey Jesch Logan

E: media@ctiseattle.com T: 206.272.4347

http://www.celltherapeutics.com/press_room F: 206.272.4434

http://www.celltherapeutics.com/investors E: invest@ctiseattle.com


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes
2. Intarcia Therapeutics, Inc. Announces Appointment of Kenneth Luskey, M.D. as Vice President, Clinical Research
3. Cell Therapeutics, Inc. Announces Reverse Stock Split
4. Cell Therapeutics, Inc.s Second Quarter 2008 Financial Results
5. Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results
6. Zenobia Therapeutics, Inc. Receives Michael J. Fox Foundation for Parkinsons Research Award for Work on PD-implicated Protein LRRK2
7. Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior Convertible Notes and Warrants
8. Zenobia Therapeutics, Inc. Begins Operations as a Fragment-Based Lead Discovery Company
9. Shareholders Approve All Matters Proposed by Cell Therapeutics, Inc. at Special Meeting in Lieu of Annual Meeting of Shareholders
10. Cell Therapeutics, Inc. Repays $11.0 million Balance of 2008 Convertible Debt
11. Cell Therapeutics, Inc. Special Meeting in Lieu of Annual Meeting of Shareholders Scheduled for Thursday, June 19, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2017)... ... October 06, 2017 , ... With ... microscopy and surface analysis, Nanoscience Instruments is now expanding into Analytical Services. ... range of contract analysis services for advanced applications. Services will leverage techniques ...
(Date:10/7/2017)... 6, 2017  The 2017 Nobel Prize in ... Jacques Dubochet, Joachim Frank and ... cryo-electron microscopy (cryo-EM) have helped to broaden ... biology community. The winners worked with systems manufactured ... produce highly resolved, three-dimensional images of protein structures ...
(Date:10/6/2017)... ... October 06, 2017 , ... On Tuesday, October 24th, ABC² ... the first-ever adaptive clinical trial for glioblastoma (GBM). The featured speaker will be ... and open to the public, but registration is required. , WHAT: ABC² ...
(Date:10/5/2017)... ... October 05, 2017 , ... Understanding the microbiome, the millions of bacteria that ... Love: You Are My Future, the newest exhibit on display at the University City ... human condition through the lens of the gut microbiome. , Gut Love opens ...
Breaking Biology Technology:
(Date:4/6/2017)... -- Forecasts by Product Type (EAC), Biometrics, ... (Transportation & Logistics, Government & Public Sector, Utilities / ... Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality ... looking for a definitive report on the $27.9bn Access ... ...
(Date:4/4/2017)... April 4, 2017   EyeLock LLC , a ... the United States Patent and Trademark Office (USPTO) has ... the linking of an iris image with a face ... represents the company,s 45 th issued patent. ... very timely given the multi-modal biometric capabilities that have ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
Breaking Biology News(10 mins):